脉络膜淀粉样沉积:晚期吲哚菁绿血管造影中淀粉样病灶的多中心研究
该多中心回顾性观察性病例系列纳入32例转甲状腺素蛋白(ATTR)或AL淀粉样变性患者,分析晚期吲哚菁绿血管造影(ICGA)特征。55眼中49眼(89%)见对应脉络膜淀粉样血管病(CAA)的晚期高荧光点,最大染色中位时间672秒(95%CI 644-752),显著晚于初始染色503秒(95%CI 447-521,P<0.0001)。7例ATTR随访者中CAA稳定2例、改善5例,但3例(43%)双眼玻璃体混浊加重,4例(57%)发生继发性开角型青光眼。
要点
- 89%的淀粉样变性患眼在ICGA极晚期可见对应CAA的高荧光点。
- 最大染色中位时间672秒,需长达12.5分钟。
- 7例ATTR随访者中CAA稳定2例、改善5例,但3例玻璃体混浊加重、4例发生继发性开角型青光眼。
核心结论
- 多数淀粉样变性患者在ICGA上可见脉络膜淀粉样血管病。
- 最大ICG染色需长达12.5分钟。
- 多数患者经全身治疗后脉络膜淀粉样血管病改善,可能作为全身疾病状态的标志物。
研究设计与样本
- 多中心回顾性观察性病例系列,纳入接受ICGA的转甲状腺素蛋白(ATTR)和AL淀粉样变性患者32例(ATTR 27例、AL 5例),平均年龄58.9±17.4岁。
主要发现
- 55眼中49眼(89%)在ICGA极晚期见对应CAA的高荧光点。
- 最大染色中位时间672秒(95%CI 644-752),显著晚于初始染色503秒(95%CI 447-521,P<0.0001,Wilcoxon符号秩检验)。
- 7例接受ICGA随访的ATTR淀粉样变性患者中,CAA稳定2例、改善5例。
- 上述7例中3例(43%)双眼玻璃体混浊加重,4例(57%)发生继发性开角型青光眼。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize choroidal amyloid angiopathy (CAA) using late-phase indocyanine green angiography (ICGA). METHODS: This was a multicenter retrospective observational case series on patients with transthyretin (ATTR) and AL amyloidosis who underwent ICGA. The timing of hyperfluorescence and longitudinal changes were analyzed. RESULTS: Thirty-two patients (27 with ATTR and 5 with AL) with mean age of 58.9 ± 17.4 years were included. Hyperfluorescent spots in the very late phases of ICGA, corresponding to CAA, were observed in 49 of 55 eyes (89%). The median time to maximal staining was 672 (95% confidence interval, 644-752) seconds, which was significantly later than the initial staining (503 [95% confidence interval, 447-521], P < 0.0001; Wilcoxon signed rank test). In seven patients with ATTR amyloidosis who underwent follow-up of ICGA, the CAA was stable in two patients and improved in five patients during treatment. However, 3 patients (43%) had worsening vitreous opacities in both eyes, and 4 patients (57%) developed secondary open-angle glaucoma. CONCLUSION: Most patients with amyloidosis were found to have CAA on ICGA. Up to 12.5 minutes is required for maximal ICG staining. Choroidal amyloid angiopathy improved in most patients with systemic treatment and may serve as a marker of systemic disease status.
引用
- Mano F, Yonekawa Y, Kakihara S, et al. CHOROIDAL AMYLOID DEPOSITION: A Multicenter Study of Amyloid Lesions Identified in Late Indocyanine Green Angiography. Retina. 2022. PMID: 36129270. doi:10.1097/IAE.0000000000003551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。